Company Description
China Jo-Jo Drugstores, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People’s Republic of China.
The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items.
The company offers consultation, examination, and treatment of common ailments by licensed doctors in western medicine and TCM at scheduled hours.
In addition, it provides treatment for minor ailments, such as sprains, minor lacerations, and dizziness; acupuncture, therapeutic massage, and cupping services; and minor outpatient surgical treatments, including suturing.
Further, it offers OTC drugs and nutritional supplements through its website www.dada360.com, as well as sells products through third-party platforms.
Additionally, the company distributes third-party pharmaceutical products to trading companies, as well as cultivates and wholesales herbs used for TCM.
It operates pharmacies under the Jiuzhou Grand Pharmacy name. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People’s Republic of China.
| Country | China |
| Founded | 2003 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 1,003 |
| CEO | Lei Liu |
Contact Details
Address: Building 5, 4th Floor Hangzhou, 310008 China | |
| Phone | 86 57 1882 19579 |
| Website | jiuzhou360.com |
Stock Details
| Ticker Symbol | CJJD |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001413263 |
| CUSIP Number | 16949A206 |
| ISIN Number | KYG2124G1120 |
| Employer ID | 98-0557582 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Lei Liu M.D. | Chairman and Chief Executive Officer |
| Ming Zhao | Chief Financial Officer |
| Steve Liu | Investor Relations Director |
| Yan Liu | Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 30, 2021 | 15-12B | Securities registration termination |
| Jul 29, 2021 | 25-NSE | Filing |
| Jul 28, 2021 | 8-K | Current Report |
| Jul 20, 2021 | 8-K | Current Report |
| Jul 1, 2021 | 8-K | Current Report |
| Jun 29, 2021 | 10-K | Annual Report |
| Jun 2, 2021 | DEF 14A | Other definitive proxy statements |
| May 14, 2021 | 8-K | Current Report |
| Apr 22, 2021 | 8-K | Current Report |
| Feb 12, 2021 | 8-K | Current Report |